Authors

• Carl Koschmann (ORCID: https://orcid.org/0000-0002-0825-7615)
• Joshua D. Parsels
• Qiang Zhang (ORCID: https://orcid.org/0009-0006-2175-2289)
• Erik Peterson (ORCID: https://orcid.org/0000-0002-6579-2948)
• Michael D. Green (ORCID: https://orcid.org/0000-0003-4951-7118)
• Robert Doherty (ORCID: https://orcid.org/0000-0001-9307-7995)
• Meredith A. Morgan (ORCID: https://orcid.org/0000-0001-7965-6878)
• Sujatha Venkataraman (ORCID: https://orcid.org/0000-0002-1512-284X)
• Zhuwen Wang (ORCID: https://orcid.org/0009-0008-1203-5979)
• Theodore S. Lawrence (ORCID: https://orcid.org/0000-0002-4186-8821)
• Daniel Wahl (ORCID: https://orcid.org/0000-0001-9894-5085)
• Zi‐An Li (ORCID: https://orcid.org/0000-0002-6338-8933)
• Sameer Agnihotri (ORCID: https://orcid.org/0000-0001-6584-3795)
• Leslie A. Parsels (ORCID: https://orcid.org/0000-0002-5880-1033)
• Stephanie The (ORCID: https://orcid.org/0000-0002-6660-4136)
• Victoria M. Valvo (ORCID: https://orcid.org/0009-0004-5837-4141)
• Xinjun Wang (ORCID: https://orcid.org/0009-0009-9298-031X)
• Nan Hu (ORCID: https://orcid.org/0000-0003-1443-2130)
• Yupei Guo
• Anushka Dalvi
• Sriram Venneti

Institutions

• University of Pittsburgh (US)
• University of Michigan (US)
• Fifth Affiliated Hospital of Zhengzhou University (CN)
• Michigan Medicine (US)
• Michigan Center for Translational Pathology (US)
• Michigan Cancer Research Consortium (US)
• Third Affiliated Hospital of Zhengzhou University (CN)
• Henan University of Economic and Law (CN)
• University of Colorado Denver (US)

Publication Details

Journal

Neuro-Oncology

Published

2025-04-03

DOI

https://doi.org/10.1093/neuonc/noaf097

Citations

4

Primary Topic

PARP inhibition in cancer therapy

Type

article

Field-Weighted Citation Impact

4.18